Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-26 @ 11:14 AM
Ignite Modification Date:
2025-12-26 @ 11:14 AM
NCT ID:
NCT06547528
Eligibility Criteria:
Inclusion Criteria:
1. Patients with histopathologically confirmed diagnosis of one of the following subtypes as defined by the 2017 revision of the WHO classification of lymphoid malignancies:
Peripheral T-cell lymphoma(PTCL)
* Angioimmunoblastic T-cell lymphoma(AITL)
* Peripheral T-cell lymphoma, NOS(PTCL-NOS)
* Nodal peripheral T-cell lymphoma with TFH phenotype(nodal PTCL with TFH)
* Follicular T-cell lymphoma(FTCL) Cutaneous T-cell lymphoma(CTCL)
* Mycosis fungoides(MF)
* Sezary syndrome Chronic lymphocytic leukemia/small lymphocytic lymphoma(CLL/SLL)
2. Relapsed or refractory patients with tumors for which no established standard therapy is available, or refractory or intolerant to existing standard therapy judged by principal investigator or subinvestigator
3. ECOG PS 0\~2
4. Life expectancy of at least 3 months
Exclusion Criteria:
1. Patients with severe complications.
2. Patients with multiple cancers.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT06547528
Study Brief:
Protocol Section:
NCT06547528